These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28964418)

  • 1. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters.
    Seder CW; Arndt AT; Jordano L; Basu S; Fhied CL; Sayidine S; Chmielewski GW; Gallo K; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2017 Nov; 104(5):1637-1643. PubMed ID: 28964418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.
    Thornblade LW; Mulligan MS; Odem-Davis K; Hwang B; Waworuntu RL; Wolff EM; Kessler L; Wood DE; Farjah F
    Ann Thorac Surg; 2018 Nov; 106(5):1460-1467. PubMed ID: 30031845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients.
    Rinewalt D; Shersher DD; Daly S; Fhied C; Basu S; Mahon B; Hong E; Chmielewski G; Liptay MJ; Borgia JA
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1344-50; discussion 1350-1. PubMed ID: 22982029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer.
    Brown LM; Louie BE; Jackson N; Farivar AS; Aye RW; Vallières E
    Ann Thorac Surg; 2016 Oct; 102(4):1110-8. PubMed ID: 27350237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
    Borgia JA; Basu S; Faber LP; Kim AW; Coon JS; Kaiser-Walters KA; Fhied C; Thomas S; Rouhi O; Warren WH; Bonomi P; Liptay MJ
    J Thorac Oncol; 2009 Mar; 4(3):338-47. PubMed ID: 19190517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
    Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer.
    Ambrogi MC; Fanucchi O; Dini P; Melfi F; Davini F; Lucchi M; Massimetti G; Mussi A
    Eur Respir J; 2015 Apr; 45(4):1089-97. PubMed ID: 25700387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Persistent Problem of Local/Regional Failure After Surgical Intervention for Early-Stage Lung Cancer.
    Judy GD; Kaidar-Person O; Deal A; Wang Y; Migliardi A; Long J; Haithcock B; Marks LB
    Ann Thorac Surg; 2018 Aug; 106(2):382-389. PubMed ID: 29723532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of newly detected lesions during postoperative surveillance for non-small cell lung cancer.
    Lee JI; Lee YJ; Park KY; Park CH; Jeon YB; Choi CH; Ko KP
    Ann Thorac Surg; 2013 Jun; 95(6):1867-71. PubMed ID: 23643548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Margins on Outcomes After Wedge Resection for Stage I Non-Small Cell Lung Cancer.
    Wolf AS; Swanson SJ; Yip R; Liu B; Tarras ES; Yankelevitz DF; Henschke CI; Taioli E; Flores RM;
    Ann Thorac Surg; 2017 Oct; 104(4):1171-1178. PubMed ID: 28669499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
    Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
    Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
    David E; Thall PF; Kalhor N; Hofstetter WL; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Wei C; Mehran RJ
    Ann Thorac Surg; 2013 Jun; 95(6):1872-7; discussion 1877. PubMed ID: 23643547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.